Health
Regeneron suspends Covid-19 antibody trial among sickest patients – UrduPoint News
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients who require high-flow…
Washington, (UrduPoint / Pakistan Point News – 30th Oct, 2020 ) :US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients who require high-flow oxygen or are on ventilators.
The move follows a recommendation from an independent data monitoring committee (IDMC) which assesses the results and advises when it’s necessary to halt a study.
“Based on a potential safety signal and an unfavorable risk/benefit profile…
-
Noosa News24 hours agoDesign and construction integrity rewarded with national award
-
Noosa News19 hours agoIs Auckland New Zealand’s New Cultural Capital?
-
General18 hours agoThree maps that show the scale of the NSW flood disaster
-
General9 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire